Company Profile
Tiziana Life Sciences Stock Price, News & Analysis
- Ticker:
- TLSA
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- United Kingdom and trades in the U
Stock performance
0.97 USD (-1.59%)
Close
Last updated: August 6, 2026
173M USD
Market cap
Why the stock is moving
The latest company update was “Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer”. TLSA changed 1.59% and closed at $0.9743 on Aug 6, 2026, indicating a relatively limited closing-price reaction to this company update.
Company overview
Business overview
Tiziana Life Sciences is a biotechnology company focused on immune modulation and respiratory or inflammatory disease applications. Its story centers on using biologic or cellular approaches to influence difficult disease pathways.
Geographic Base and Sector Classification
Tiziana is headquartered in the United Kingdom and trades in the U.S. market. It sits in small-cap biotechnology.
Business Model Characteristics
The company depends on translational progress, clinical validation, and strategic focus across a narrow pipeline. Investors usually watch early data and whether the platform can sharpen its therapeutic thesis.
Position Within the Biotechnology Landscape
Tiziana occupies a niche immune-modulation position within biotech. It is a catalyst-driven small-cap name where scientific proof matters more than commercial scale.
Future catalysts
Tiziana’s catalysts are foralumab and the neuro / autoimmune programs, with any update that clarifies whether the platform can still progress. The market will want a cleaner clinical path.
Recent news
- 01
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
Source: Tiziana Life Sciences
- 02
- 03
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman
Source: Tiziana Life Sciences
- 04
Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial
Source: Tiziana Life Sciences
- 05
Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York
Source: Tiziana Life Sciences
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Tiziana Life Sciences (TLSA)?
Tiziana Life Sciences (TLSA) most recently closed at 0.97 USD, a -1.59% move versus the previous session.
What is the market cap of Tiziana Life Sciences (TLSA)?
Tiziana Life Sciences currently has a market capitalization of 173M USD on BioPharmSignal.
What does Tiziana Life Sciences do?
Tiziana Life Sciences is a biotechnology company focused on immune modulation and respiratory or inflammatory disease applications. Its story centers on using biologic or cellular approaches to influence difficult disease pathways.
On which exchange is TLSA stock listed?
Tiziana Life Sciences (TLSA) is associated with NASDAQ, United Kingdom and trades in the U, MedTech.
What is foralumab?
Tiziana’s catalysts are foralumab and the neuro / autoimmune programs, with any update that clarifies whether the platform can still progress.
Which conditions is Tiziana Life Sciences targeting with foralumab?
Tiziana Life Sciences is associated with respiratory disease based on its company overview and current catalyst commentary.
How does Tiziana Life Sciences describe recent progress with foralumab?
Tiziana’s catalysts are foralumab and the neuro / autoimmune programs, with any update that clarifies whether the platform can still progress.
What is Tiziana?
Tiziana Life Sciences is a biotechnology company focused on immune modulation and respiratory or inflammatory disease applications.